论文部分内容阅读
目的:评价机器人辅助腹腔镜术治疗压迫大血管的嗜铬细胞瘤和副神经节瘤的可行性和安全性。方法:回顾性分析2012年5月~2013年10月间所行4例机器人辅助腹腔镜肾上腺嗜铬细胞瘤切除术和2例机器人辅助腹腔镜副神经节瘤切除术患者的临床资料:所有患者术前均通过内分泌检查和影像学检查定性定位。手术采取侧卧位经腹腔途径。通过记录患者的人口学数据、肿瘤大小、手术时间(operating time,OT)、失血量(estimated blood loss,EBL)、术中血压波动次数(intraoperative blood fluctuation,IBF)、住院天数(hospital stay,HS)及术后内分泌随访情况来分析手术效果。结果:所有手术均成功完成,中位肿瘤直径、OT、EBL、IBF和HS分别为73mm、102.5min、120ml、3次和4.5天。术后1个月随访时,所有患者术前升高的血变肾上腺素(metanephrine,MN)或血变去甲肾上腺素(normetanephrine,NMN)均恢复正常。结论:采用机器人辅助腹腔镜手术治疗压迫大血管的肾上腺嗜铬细胞瘤或副神经节瘤是安全可行的。
OBJECTIVE: To evaluate the feasibility and safety of robot assisted laparoscopy in the treatment of pheochromocytoma and paraganglioma in the compression of large vessels. Methods: The clinical data of 4 cases of robotic assisted laparoscopic adrenal pheochromocytoma resection and 2 cases of robot assisted laparoscopic parathyroid ganglionectomy were analyzed retrospectively from May 2012 to October 2013: All patients Preoperative examination by endocrine and imaging qualitative positioning. Surgery to take the lateral position by the abdominal route. By recording demographic data, tumor size, operating time (OT), estimated blood loss (EBL), intraoperative blood fluctuation (IBF), hospital stay (HS) ) And postoperative endocrine follow-up analysis of surgical results. RESULTS: All procedures were successfully completed. The median tumor diameter, OT, EBL, IBF and HS were 73 mm, 102.5 min, 120 ml, 3 and 4.5 days, respectively. At 1 month after surgery, all patients had preoperative elevation of metanephrine (MN) or normetanephrine (NMN) returned to normal. Conclusion: It is feasible and safe to use robotic-assisted laparoscopic surgery for the treatment of adrenal pheochromocytoma or paraganglioma in the compression of large vessels.